Vahe Bedian

This inventor holds 29 USPTO granted patents and 9 published patent applications, plus 5 CIPO patents and 9 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Amgen Fremont Inc., Pfizer Corporation, Medimmune Limited. Active years: 2007-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vahe Bedian. Retrieved from https://idiyas.com/inventor/vahe-bedian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 9)

% Patents Active = 51.7

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 6)

Average Co-Inventor Count = 5.0

ph-index = 11

Forward Citations = 424(Granted Patents)

Location History:

Lyme, CT (US) (2008 - 2012)
Waltham, MA (US) (2012 - 2015)
East Lyme, CT (US) (2007 - 2019)
Framingham, MA (US) (2009 - 2019)

Company Filing History:

Warner-Lambert Company

where one patent can have more than one assignee

Years Active: 2007-2019

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

Angiopoietin-2

M-CSF

DLL4

c-Met

CD40

KDR

IGF-IR

Cancer Treatment

Tumor Therapy

Immune Response Enhancement

Nucleic Acid Molecules

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10329345 - Stabilized angiopoietin-2 antibodies and uses thereof (2019-06-25),

2. 10280219 - Antibodies to M-CSF (2019-05-07),

3. 9718883 - Antibodies to M-CSF (2017-08-01),

4. 9221915 - Human monoclonal antibodies to activin receptor-like kinase-1 (2015-12-29),

5. 9206255 - Nucleic acid molecule encoding target antibodies directed to DLL4 (2015-12-08),

6. 8894998 - Antibodies directed to αVβ6 and uses thereof (2014-11-25),

7. 8821869 - Treatment methods using c-Met antibodies (2014-09-02),

8. 8663636 - Method of treating a malignant tumor by administering antibodies directed to DLL4 (2014-03-04),

9. 8562985 - Antibodies to c-Met (2013-10-22),

10. 8507656 - Stabilized angiopoietin-2 antibodies and uses thereof (2013-08-13),

11. 8398975 - Antibodies directed to αVβ6 and uses thereof (2013-03-19),

12. 8388971 - Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses (2013-03-05),

13. 8192738 - Targeted antibodies directed to DLL4 (2012-06-05),

14. 8188249 - Nucleic acid molecules encoding antibodies to M-CSF (2012-05-29),

15. 8163280 - Antibodies to c-Met (2012-04-24),

Title: Vahe Bedian - Pioneering Inventor from East Lyme

Introduction: Vahe Bedian is a distinguished inventor hailing from East Lyme, CT, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Vahe Bedian holds several patents in the areas of renewable energy, sustainable materials, and advanced electronics, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Vahe Bedian has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized the industry.

Collaborations: Throughout his career, Vahe Bedian has collaborated with top engineers, scientists, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Vahe Bedian's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of various industries.

Profile summary based on public USPTO records.